Bennet
S.T., Lucassen A.M., Gough S.C.L., Powell E.E., Undlien D.E. Protchard L.E.,
Merriman M.E., Kawaguchi Y., Dronsfield M.J., Pociot F., et al., (1995), “Susceptibility
to human type 1 diabetes at IDDM2 is determined by tandem repeat variation
at the insulin gene minisatellite locus.” Nat. Gen., 9:284-92.
Carey
A.H., Chan K.L., Short F., White D., Williamson R., Franks S. (1993) “Evidence
for a single gene effect in polycystic ovaries and male pattern baldness.”
Clin. Endocrinol. 38: 653-8.
Carmina
E., Koyama T., Chang L., Stanczyk F.Z., Lobo R.A., (1992) “Does ethnicity
influence the prevalence of adrenal hyperandrogenism and insulin resistance
in polycystic ovary syndrome ?” Am. J. Obstet. Gynecol., 167:1807-12. Cresswell
J.L., Barker D.J.P., Osmond C., Egger P., Phillips D.I.W., Fraser R.B. (1997)
“Fetal growth, length of gestation, and polycystic ovaries in adult life.”
Lancet, 350:1131-5.
Ferriman
D., Purdie A.W. (1979) “The inheritance of polycystic ovarian disease and
a possible relationship to premature balding.” Clin. Endocrinol., 11: 291-300.
Franks
S., Gharani N., Waterworth D., Batty S., White D., Williamson R., McCarthy
M. (1997) “The genetic basis of polycystic ovary syndrome.” Hum. Reprod.,12:2641-8.
Friedman
J.M. (1997) “The alphabet of weight control.” Nature, 385:119-20.
Gharani
N., Waterworth D.M., Batty S., White D., Gilling-Smith C., Conway G.S., McCarthy
M., Franks S., Williamson R. (1997) “Association of the steroid synthesis
gene CYP11a with polycystic ovary syndrome and hyperandrogenism.” Hum. Mol.
Genet., 6:397-402.
Govind
A., Obhrai M.S., Clayton R.N. (1999) „Polycystic ovaries are inherited as
an autosomal dominant trait: analysis 29 polycystic ovary syndrome and 10
control families.“ J. Clin. Endocrinol. Metab., 84: 38-43.
Hague
W.M., Adams J., Reeders S.T., Peto T.E., Jacobs H.S. (1988) “Familial polycystic
ovaries: a genetic disease?” Clin. Endocrinol. (Oxf), 29;: 593-605.
Holte
J. (1996) “Disturbances in insulin secretion and sensitivity in women with
the polycystic ovary syndrome.” Clin. Endocrinol. Metab., 10:221-47.
Jahnfar
S., Eden J.Z., Warren P., Seppala M., Hgyun T.V. (1995) “A twin study of polycystic
ovary syndrome.” Fertil. Steril., 61:478-86.
Kiddy
D.S., Hamilton-Farley D., Bush A., Short F., Anyaoku V., Reed M.J., Franks
A.D. (1992) “Improvement in endocrine and ovarian function during dietary
treatment of obese women with polycystic ovary syndrome.” Clin. Endocrinol.
Oxf., 36:105-11.
Legro
R.S., Kunselman A.R., Dodson W.C., Dunaif A. (1999) “Prevalence and predictors
of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic
ovary syndrome: a prospective, controlled study in 254 affected women.” J.
Clin. Endocrinol. Metab., 84: 165-169.
Lunde
O., Magnus P., Sandvik L., Hoglo S. (1989) “Familial clustering in the polycystic
ovarian syndrome.” Gynecol. Obstet. Invest., 28: 23-30.
Mac
Dougall M.J., Tan S.L., Balen A., Jacobs H.S. (1993) “A controlled study comparing
patients with and without polycystic ovaries undergoing in-vitro fertilization.”
Hum. Reprod., 8:233-7.
Olson
B.R., Cartledge T., Sebring N., Defensor R., Nieman L. (1995) “Short-term
fasting affects luteinizing hormone secretory dynamics but not reproductive
function in normal-weight sedentary women.” J. Clin. Endocrinol. Metab., 80:1187-93.
Waterworth
D.M., Bennett S.T., Gharani N., McCarthy M.I., Hague S., Batty S., Conway
G.S., White D., Todd J.A., Franks S., Williamson R. (1997) “Linkage and association
of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.”
Lancet, 349:986-90.
Zaadstra
B.M., Seidell J.C., Van Noord P.A., te Velde E.R., Habbema J.D., Vrieswijk
B., Karbaat J. (1993) “Fat and female fecundity: prospective study of effect
of body fat distribution on conception rates.” Br. Med. J., 306:484-7.
Zhang
L.H., Rodriguez H., Ohno S., Miller W.L. (1995) “Serine phosphorylation of
human P450c17 increases 17,20-lyase activity: implications for adrenarche
and the polycystic ovary syndrome.” Proc. Natl. Acad. Sci. USA, 92:10619-23.
